Thursday, 23 December 2021

FDA officially authorizes anti-viral pill to treat COVID-19

Add TODAY to your contacts | View in browser
FDA officially authorizes anti-viral pill to treat COVID-19
There's new hope in the fight against the coronavirus, after the FDA authorized an anti-viral pill from Pfizer on Wednesday.
Watch Now
Thursday expected to be heaviest travel day before Christmas
Right now millions of Americans are gearing up to travel, with today expected to be one of the busiest for the nation's roads and airports.
Watch Now
Biden extends student loan freeze until May
President Joe Biden has extended the nearly two-year freeze on federal student loan payments for an additional three months.
Watch Now
'Wheel of Fortune' contestant wins big after losing prize
After losing out on the prize, an Audi Q3, the automaker reached out to personally gift her a new ride.
Watch Now
6 stylist-approved extensions for long hair without the wait
Looking to try temporary hair extensions? Experts recommend these picks.
Read More
Should people be paid to get the COVID-19 vaccine or booster?
Critics worry a payment can send the wrong message.
Read More
This bestselling detox shampoo gave my scalp new life
It's also giving my curly locks the hydration and shine they deserve.
Read More
Related
Why Queen Elizabeth won't be spending Christmas at traditional country estate
Watch Now
Watch TODAY All Day!
Read More
Download the TODAY app for more updates
Read More
Get the TODAY Mobile App
Apple Google
Follow TODAY
Facebook Pinterest Instagram Youtube Youtube Youtube
Update Preferences | Unsubscribe | Contact | Privacy
Share this post
  • Share to Facebook
  • Share to Twitter
  • Share to Google+
  • Share to Stumble Upon
  • Share to Evernote
  • Share to Blogger
  • Share to Email
  • Share to Yahoo Messenger
  • More...

0 comments

:) :-) :)) =)) :( :-( :(( :d :-d @-) :p :o :>) (o) [-( :-? (p) :-s (m) 8-) :-t :-b b-( :-# =p~ :-$ (b) (f) x-) (k) (h) (c) cheer

 
© test1
Designed by BlogThietKe Cooperated with Duy Pham
Released under Creative Commons 3.0 CC BY-NC 3.0
Posts RSSComments RSS
Back to top